Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
about
The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the diseaseEmerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancerThe significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosisChallenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, miceOvercoming macrophage-mediated axonal dieback following CNS injuryEndoneurial remodeling by TNFalph- and TNFalpha-releasing proteases. A spatial and temporal co-localization study in painful neuropathy.Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy.Advances in ischemic stroke treatment: neuroprotective and combination therapies.The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer.Cortical spreading depression activates and upregulates MMP-9.Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice.Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cellsA novel synthetic oleanane triterpenoid suppresses adhesion, migration, and invasion of highly metastatic melanoma cells by modulating gelatinase signaling axis.Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions.Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life settingCytokines in multiple sclerosis: methodological aspects and pathogenic implications.Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophyParallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformisExpression of aminopeptidase N (APN) on peripheral blood mononuclear cells' surface as a marker of these cells' transendothelial migration properties in the course of multiple sclerosis.Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.Serum matrix metalloproteinase-3 levels correlate with disease activity in relapsing-remitting multiple sclerosis.The potential use of MMP inhibitors to treat CNS diseases.Matrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets.Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis.Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion diseaseDifferential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancersDepression and immunity: inflammation and depressive symptoms in multiple sclerosis.Matrix metalloproteinases as drug targets in preeclampsiaSynthesis and evaluation of novel heterocyclic MMP inhibitors.Targeting MMPs in acute and chronic neurological conditions.Wasting mechanisms in muscular dystrophy.Matrix metalloproteinase-9 inhibition ameliorates pathogenesis and improves skeletal muscle regeneration in muscular dystrophy.Cathepsins and their endogenous inhibitors cystatins: expression and modulation in multiple sclerosisGABRA3 promotes lymphatic metastasis in lung adenocarcinoma by mediating upregulation of matrix metalloproteinases.CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine.Angiogenesis-related genes may be a more important factor than matrix metalloproteinases in bronchopulmonary dysplasia development.Matrix metalloproteinases and their pathological upregulation in multiple sclerosis: an overview.The role of microglia and matrix metalloproteinases involvement in neuroinflammation and gliomas
P2860
Q24676476-6E515321-EA90-483C-A988-B286FD035E41Q26778509-455B1ACF-A45C-4B4B-B3FD-510122132658Q27009126-045395DC-2017-4D83-ACC5-CCE89A3FC991Q28506176-F622F752-E82C-4005-B801-5D3BC90BD4E1Q30491369-4617F9E3-3313-4DF7-8548-0430AE1DAFE5Q30830869-2ED70951-3735-4017-BD50-F61FF5A0F6DCQ32001558-6FF6F9C7-B7A9-4C80-B18E-88F35791C5E9Q33278117-BBE6CBF8-219F-48D2-8704-62DBFBBBB8B2Q33693020-13F0840C-0517-45DA-9F95-D6B6B43A6E3EQ33785624-4CF233AD-A0B4-41D1-825D-A71BB785EF46Q33947243-5ACF9746-D076-411D-8D3B-52ED44D31ED2Q34003220-F5A36196-BA5B-4F79-B697-CDBE1AA9103CQ34005707-5AC8E89A-4033-4BE0-B90B-8DAAA5F15F31Q34022900-0018622F-AB3B-4E48-AF11-EFBEDE783528Q34137763-A6624C6E-BE4C-40DA-A62F-F1D1B2649825Q34480272-3A1BB5A2-EEB1-4F4E-8A62-496CD392F20AQ34650470-D4EBF36D-DBF9-4F50-B055-C549C9958ECAQ34924266-4E732C22-5639-45D1-A2D8-8DABAF925685Q35175749-B5352B26-42E8-49E8-9DE3-5412E2CF2CD0Q35363095-91E964B6-5EB4-42E1-AEF4-0311DE05D1D2Q35609648-0510D325-51F8-4785-AEAE-C1CD9B0E5159Q35677091-DC344DFB-957A-43E3-9467-7BC9BB6C9862Q36142537-16AF8C96-ACC5-4BB6-BD4B-555AE5B520F1Q36181275-160B246F-B179-4396-AA61-A22438FB6121Q36210614-D79288C2-E110-4804-85C8-6B67702D2AECQ36326348-FBE98A72-A70D-49B4-85FB-F80B8D53536EQ36343836-2581C89F-FB54-49F4-AB2D-29738DD0C7AFQ36622753-0B5B7BAB-082F-46AC-A81C-EB3B42B00867Q36764298-8C0E0065-4993-4256-902D-2A982E7B1948Q36910638-95D07A9F-1CCA-4562-885B-89DE5001A8ACQ36953454-02F1E0B4-F61A-4A73-9E7A-DB73D148E7D6Q36963155-55242FE8-10F5-4495-97FD-8574388F2A08Q37138490-3B8872CA-6C0A-422F-BD41-8F672F97E5FFQ37239871-5474EC5F-99B8-4F14-A30E-AC26335A9A9DQ37294866-2C5CC1C6-EDFA-4278-A9FF-7217D117964EQ37362669-BC2E65A4-FBC3-4434-8B11-486C0AF9234BQ37630537-EFDE5273-65D9-4B26-9CB3-E5D8E19885F0Q37745798-87FCCB62-4F72-425C-A2AD-FD5AE5A513A2Q38134015-DE96CFAC-952B-4F74-9A06-6FA07718F019Q38136195-7056D258-505D-4087-95FC-A08699885E11
P2860
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
@ast
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
@en
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
@nl
type
label
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
@ast
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
@en
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
@nl
prefLabel
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
@ast
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
@en
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
@nl
P2093
P1476
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview.
@en
P2093
Chandler S
Clements JM
Gearing AJ
P304
P356
10.1016/S0165-5728(96)00179-8
P577
1997-02-01T00:00:00Z